Julie J Miller

14PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Jun 12, 2026
IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma.

|Aug 16, 2024
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas.

Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia

|Jul 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.

Eric P Grewal, Leland G K Richardson, Jing Sun

|May 08, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition.

Ali M Nasser, Lisa Melamed, Ethan A Wetzel

|Dec 16, 2022
IDH-mutant glioma: A new IDH1 inhibitor moves forward.

Julie J Miller, Isabel Arrillaga-Romany

Pageof 3

Frequent Collaborators

4 joint publications

Daniel P Cahill

3 joint publications

Hiroaki Wakimoto

2 joint publications

Hidetoshi Murata

2 joint publications

Kensuke Tateishi